CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022
Cash flow from operating activities
Net loss	$ (3,199)	$ (12,706)	$ (9,902)
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation		554	642
Amortization of right of use assets		71	67
Depreciation		66	65
Change in fair value of warrant liability	(72)	(72)
(Increase) decrease in operating assets
Prepaid drug product		2,955	(1,824)
Other current assets		(174)	(297)
Increase (decrease) in operating liabilities
Accounts payable and accrued expenses		(335)	1,220
Lease liabilities		(80)	(74)
Net cash used in operating activities		(9,721)	(10,103)
Cash flow from investing activities
Purchases of furniture, fixtures & equipment			(21)
Net cash used in investing activities			(21)
Cash flow from financing activities
Net proceeds from sale of common stock		1,689
Net cash provided by financing activities		1,689
Net decrease in cash		(8,032)	(10,124)
Cash, beginning of period		10,384	23,774
Cash, end of period	$ 2,352	$ 2,352	13,650
Non-cash operating activities
Right of use asset recognized in exchange for lease obligation			$ 85